Weekly Psychedelic Policy Briefing β August 14, 2026
The FDA has finalized guidance on clinical investigations into psychedelic-assisted therapies and contract research organization ICON will bring Anthropic's Claude AI tool into clinical trials involving drug development. The post Weekly Psychedelic Policy Briefing β August 14, 2026 first appeared on Lucid News.
External link. We are not responsible for the content.
Read more βMore From Lucid News
Psychedelic Policy Briefing
In this week's psychedelic policy briefing, investigative journalist Jack Gorsline unpacks a wave of state and federa...
Have You Had Difficulties After a Trip? The Emory Center for Psychedelics and Spirituality Wants to Hear From You
An international research consortium including Brown University, the University of Melbourne, the University of North...
Approval Is Not Access: A Postcard From Psychedelic Europe
At ICPR 2026 at the historic city ofin Haarlem in the Netherlands, the companies racing to turn psychedelics into app...
Latest News
Whatβs the difference between recreational and therapeutic psychedelic use? 5 Questions with experimental psychologist Harriet de Wit
De Wit discusses the difficulty of finding out what a drug does, outside of its context.
World Ayahuasca Forum Brings Ancestral Intelligence to Spain
PLUS, an interview with an iconic Grateful Dead artist, ayahuasca and loneliness, and Puerto Rico's executive order. ...
Citizen Science x Phenomenology
Journaling, editing, reflecting, integrating β all remain valid when formalising your anecdotal report, to make sense...
The Psychedelic Future We Were Promised
This Week's Sunday Insider: Why the Psychedelic Future Never Arrived.
Veterans Affairs continues to drive federal psychedelics push; New FDA guidance; and Resilient Pharmaceuticals tries again for MDMA approval
Plus: Pharmaceutical giant Eli Lilly makes a psychedelics acquisition; Cardiovascular safety is top of mind for psych...
9 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states sha...